Event Content

As the pharmaceutical landscape evolves, the demand for large-volume subcutaneous (LVSC) injections is rapidly growing—driven by the need for home-based treatments, improved patient comfort, and a shift from intravenous (IV) to subcutaneous (SC) delivery. Longer injection times are now clinically accepted,...

Sustainability is currently one of the key priorities in the pharma industry. Large companies have pledged targets e.g. on carbon emissions, plastic neutrality and other objectives. The cGMP and other regulatory frameworks for pharmaceutical packaging however sets boundaries for the development and product...

• Status and Accessibility of Biologics: The Biologics Market is Growing Rapidly & Poor Accessibility of Biologics, Challenges and Solutions • Pathway to $10/g Biologics Production: · Breakthrough Technology: Ultra-large scale Production Line, Innovative Manufacturing Processes: Epic-CHO@ Cell Line ...

This presentation examines evolving therapeutic antibody processes. Processing of conventional mAbs continues to mature, while new chromatography approaches are required for multispecifics and fragments—as a one-size-fits-all strategy has become outdated. Optimizing capture requires selecting processes bas...

In today’s evolving healthcare landscape, centering the patient voice is more crucial than ever. Join our keynote as we explore how integrating patient perspectives enhances clinical outcomes, drives innovation, and fosters trust across the industry.

Developing small molecule drugs can be exceptionally challenging. Pharmaceutical companies face high costs, huge attrition rates and considerable risk. Therefore, understanding the pitfalls that can impede early development, and how the associated risks can be effectively managed, will ultimately drive a p...

As GLP-1 therapies gain traction in combating obesity nationwide, their success is transforming the pharmaceutical landscape.

This panel brings together experts to discuss the latest technological breakthroughs revolutionizing advanced bio-manufacturing. From AI-driven automation to cutting-edge bioprocessing tools, we’ll examine how these innovations are enhancing scalability, precision, and efficiency in biologics production. ...

Subcutaneous technologies have demonstrated real advantages in healthcare provision and have become a growth driver that doesn’t look to slow with upcoming adoption by weight-loss, oncology and immunology therapies. By advancing biologic therapies to subcutaneous presentations, we not only enhance patient ...

The sub-cutaneous injection of larger drug volumes is an emerging field of drug application driven by recent advances in formulation development and novel therapeutic areas. In the context of the hospital to homecare shift handheld auto-injectors have been developed to a larger volume design and pumps with...

Laurie Brunet-Manquat is the Clinical and Human Factors Manager for Advanced Drug Delivery Systems (ADDS) Platform within BD Medical - Pharmaceutical Systems. Laurie achieved a master’s degree in health engineering specialized in clinical research in 2018 at Grenoble, France. She worked for 2 years as Clin...

As biopharma companies increasingly seek to optimize the drug development timeline, China has emerged as a cost-effective biomanufacturing hub for both the rapidly growing Chinese market and the rest of the world. New localization guidelines set by the NMPA’s Center for Drug Evaluation encourage global com...

Join our panel of experts as they will examine the differences between clinical and commercial packaging in the pharmaceutical industry. Key topics include scaling up from clinical trials to commercial production, complying with global regulations, and ensuring patient safety and efficient supply chains. A...

Join us on day 2, into the potential of biosimilars to expand access to critical treatments for patients. • We'll explore how these medications can play a significant role in healthcare, while also discussing the opportunities and challenges associated with their wider adoption.

Pharma is often perceived as lacking innovation outside its core R&D operations. However, the venture capital arms of major pharmaceutical companies play a crucial role in driving innovation and tackling significant healthcare challenges. Join this panel discussion to gain the latest insights into the curr...

The pharmaceutical industry is facing increased pressure to reduce costs, and one approach is to improve manufacturing efficiency. Join our panel, where experts will review the latest technologies, re-design processes, and optimizing workflows, so drug manufacturers can reduce costs. • Why Expanding ...

Antibody-drug conjugates (ADCs) are pioneering biologics that merge antibodies’ specificity with small molecules’ potency. With a handful of FDA-approved ADCs in the market and many under development, ADCs are poised to revolutionize therapeutics. This talk examines the complexities of ADC production, emph...

Ingenza is changing the game in drug substance production by embracing the concept of employing the best of what both chemistry and biology have to offer. We integrate fermentative, biocatalytic and chemical synthetic transformations at any stage in the manufacturing process. We are versatile and adaptable...

Cyclodextrins (CDs) - explore novel applications in neurodegenerative diseases, gene therapy, and biotechnology, showcasing innovative structures, mechanisms, challenges, and results, with a focus on Alzheimer's, Parkinson's, rare genetic disorders, and potential expansion to longevity and infectious disea...

The healthcare landscape is experiencing a significant shift as traditional hospital-based care transitions to the home where feasible, enabled by innovative technologies supporting remote care, monitoring, and patient engagement. This talk aims to underscore the importance of preparing for this evolving e...

As the landscape, development, and introduction of large-volume delivery systems continue to grow, the implementation of these devices in the Pharma ecosystem creates unique challenges for pharmaceutical companies. From the selection of drug containment materials and enclosures, to device assembly needs to...

Vaporized Hydrogen Peroxide (VHP or VH2O2) is a growing option for sterilizing pre-filled syringes that contain an aseptically filled biological product. The sterilization of the syringe exterior surfaces, packaging, and associated components allows for a sterile presentation to the patient reducing th...

Where are all the On Body Delivery Devices? On Body Large Volume Injectors (LVI) have been discussed and demonstrated for over ten years, but very few of these devices have reached the hands of patients. Two of CDPs combination product experts will outline the barriers that these products have faced in ...

Cell & Gene Therapies bring a promising future for many serious and rare disease patients. However, manufacturing these treatments represent a lot of challenges and can represent a barrier to the development and thus limiting broader access to these promising cures.
Seqens, with the ongoing acquisit...

The changing healthcare system increases the necessity for a more patient-centric approach. Join patient advocate Heidi Floyd, where she will delve into how pharma can create a robust patient-centric supply chain, such as:
• Developing greater collaboration and communication between suppliers, ma...

Understanding the impact of ingredient quality on pharmaceutical companies of all sizes is essential. Join this presentation to dive deeper into ingredient quality trends and solutions available to minimize risk. This presentation will address: • Potential impact to pharmaceutical companies concerning ...

With a science-based target set for 2030, Merck has launched a Supplier Decarbonization Program to lower the greenhouse gas emissions along its supply chain. Creating transparency of the emissions associated with the products Merck purchases is key to understanding how this reduction is progressing. Compan...

Where QBD was the orchestral sheet music that determined how drug product development has been harmonized over the last 15 or so years, contemporary patient-centric risk-based approaches to drug development are the pop evolution. The music is still beautiful when produced well - but the focus is no longer...

In The CDMO X-Factor,Andrew Carpenter, Ph.D, a leader in cGMP manufacturing of small molecule APIs, with a passion for continuous manufacturing, will challenge the boundaries of what the industry once believed possible for advanced pharmaceutical ingredients manufacturing. This engaging session will includ...

AI an ever growing in pharma and is playing a prominent role in drug development. Listen to the latest developments in AI and what you need to know to utilize its potential in drug development. Join our focused session to get key takeaways from our expert: • Understanding what AI can bring to your orga...

In pharma, it is essential to identify the right partner to ensure a successful outcome. Time and time again, mistakes have been made in this process, causing clinical studies to fail and for the company to take a heavy hit. Want to avoid this? join our one-hour masterclass where we will devise a checklist...

OXYCAPT is a multilayer plastic vial that consists of three layers, COP/New Polyester/COP. The product has achieved excellent oxygen & ultraviolet (UV) light barrier, very low extractables, high pH stability, low protein adsorption, high transparency, high break resistance, lightweight, etc. For example, t...

For the past 20 years in healthcare, Polypropylene (PP) has been the most utilized plastic across a range of applications, from high-risk applications such as IV parenteral packaging to medical devices and diagnostics. PP offers alternatives to glass, metal and other plastics, such as PS or PVC. The press...

We at Körber believe the pharmaceutical industry will ultimately dispense of plastic packaging within a few years. Our Rondo Solutions are pioneering when it comes to sustainability. Today pharmaceutical packaging expects to be innovative, compact, safe, and environmentally friendly. That’s because opin...

Our healthcare industry is evolving. The move from IV to SC injection is being driven by lifecycle management, biosimilar adoption, and the hospital to home trend. Molecules are getting more complex, and patients drive the preference for self-administration resulting in the need for more complex combinatio...

This leadership-powered panel discussion will touch upon some of the actions, challenges and the way ahead for producers of fine chemicals to achieve manufacturing excellence through sustainable competitiveness, growth and the promotion of responsible global environmental performance.

Technological innovation in Pharma and Life Science is happening now!

Metaverse, Artificial Intelligence, Data Analytics, Machine Learning, Digitalization: these topics are ranking high on the agenda of the business leaders who understand the competitive advantages that can be seized by moving n...

It’s a hard pill to swallow, but medication adherence is a crucial issue today. For oral formulations in pharma and nutraceuticals, taste, appearance, and aroma directly impact patient compliance and consumer experience.
Choosing the right excipients to provide optimum performance while continuing t...

Rapid climate change has direct impacts on human health. These arise from multiple causes, including severe weather, changing ecology of disease vectors, increased allergens, and geopolitical conflict over scarce resources.
Healthcare itself contributes to climate change because of its sizeable carb...

In this webinar, originally broadcast as part of Pharmapack Europe 2022, Chris Muenzer, Vice President of Innovation & Development, Haselmeier, a medmix Brand discusses how development of an integrated drug delivery device is a complex exercise that requires expertise in medical device engineering and phar...

In this webinar, originally part of Pharmapack Europe 2022, Bernd Garska, Technical Marketing Manager Healthcare EMEA, Covestro AG discusses how until now, drug delivery devices would require tedious sorting with a variety of materials used in various components. Now, with an all-polycarbonate device, mini...

In this webinar, originally broadcast as part of the Pharmapack Europe show, Katsuyuki Takeuchi, Associate Product Manager, Terumo Europe NV will discuss how the world, and in particular the world of Plastics needs to change its Consumption, Production and Value Creation practices. Global Challenges such a...

In this webinar, originally broadcast as part of the Pharmapack Europe show, Felix Georg Müller, CEO & Co-Founder, plus10 GmbH introduces the company's innovative and GMP-compliant AI-tools for automated pharmaceutical production and packaging lines. The focus of the presentation is a detailed best practic...

As clients seek to gain maximum benefit from each clinical stage, the advantages offered by contract partners with integrated services are making these higher returns tangible. This presentation will highlight key activities under Thermo Fisher’s integrated drug substance and product development services f...

Join our panel discussion, where out experts will conduct a deep dive through the challenges in drug manufacturing. Key discussion points include: Bottlenecks in skilled workforce and what can be done to overcome this Assessing the challenges in both product and manufacturing quality and identifying...

Q&A featuring Raman Sehgal, host of Molecule to Market and Stephanie Watson, Global Strategy and Commercial Planning Lead at Pfizer CentreOne Diving into the biggest challenges the supply chain are currently facing, as well as potential solutions Dissect successful responses and shed light on the future tr...

As global governments and businesses increasingly make bold claims and commitments to tackle the climate emergency, investors are starting to take note by using the ESG framework to move beyond environmental concerns and focus on a company's impact on all the different ecosystems it operates in. The ris...